Binding agonist for treatment of neurological and other disorders
US11078287B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2016 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Aug 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to TrkB binding agonists, and to the use of such agonists in the treatment of neurological disorders and other disorders. The present invention also relates to specific TrkB binding agonists comprising CDRs, variable regions, heavy and light chains, and variant sequences thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.